A multi-center, open label trial to demonstrate the clinical effectiveness and safety of Gengraf® and Prograf® in Renal Transplant patients

Gengraf-Prograf Trial

General Information

Research Type

Interventional

Description

This is a multi-center, open label, single treatment arm trial designed to demonstrate the clinical effectiveness and safety of Gengraf® and Prograf®.
120 patients with de novo renal allograft from about 16 participating sites who meet inclusion/ex

Study Information

RMK Priority Area

Research Level

Research Keyword

Inclusion & Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Study Timeline

Expected / Actual Date Study Starts - First Enrolment of subject / Collecting data

Jan, 02 2003

Expected / Actual Date Study Completed

Jun, 09 2005

Expected / Actual Duration of Study Enrollment / Data Collection

127 weeks